Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Tricuspid RegurgitationHeart Failure NYHA Class IIIHeart Failure NYHA Class IV
Interventions
DEVICE

Left ventricular assist device (LVAD)

Left ventricular assist device placement (LVAD). All participants will receive an LVAD as a part of routine care for their advanced heart failure.

PROCEDURE

Tricuspid Valve Repair (TVR)

Participants will be randomly assigned to receive a tricuspid valve repair (TVR) to repair their tricuspid valve regurgitation in addition to an LVAD placement. Only half of enrolled participants will receive this procedure.

Trial Locations (1)

98195

RECRUITING

University of Washington Medical Center, Seattle

All Listed Sponsors
collaborator

Society of Cardiovascular Anesthesiologists

UNKNOWN

lead

University of Washington

OTHER